PROCEPT BioRobotics
PRCT----
PROCEPT BioRobotics (PRCT)
PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology in the United States and internationally. It develops...
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- --
- Volume
- --
- Turnover
- --
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- --
- Volume Ratio
- --
- Turnover Ratio
- --
PROCEPT BioRobotics Analyst Rating
View MoreForecast & Rating
Jul 15, 2026Price forecast
$29.3075.55%
Forecast & RatingBuy
13analysts
- Strong buy38.46%
- Buy7.69%
- Hold46.15%
- Sell0.00%
- Strong sell7.69%
News
- MorningStar · 1 day ago, 07:44 PM
PROCEPT BioRobotics Corporation (NASDAQ: PRCT) Investors Who Suffered Losses May Be Eligible to Participate in Securities Class Action; Contact Robbins LLP for Information About Recovering Your Losses
- PUBT · Jul 14 at 03:06 PM
Procept BioRobotics to report Q2 results after market close, host conference call
- Tip Ranks · Jul 6 at 09:45 PM
Truist Financial Sticks to Its Hold Rating for PROCEPT BioRobotics (PRCT)
- PUBT · Jun 29 at 12:16 PM
Procept BioRobotics posts investor presentation outlining Aquablation growth strategy in BPH market
- benzinga_article · Jun 24 at 06:35 AM
This Take-Two Interactive Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday
- Simplywall · Jun 23 at 02:03 AM
PROCEPT BioRobotics (PRCT) Is Down 6.5% After Institutional Ownership Surges Past Shares Outstanding Has The Bull Case Changed?
